CHELCIE LANGLOIS: Open Payments
NPI 1477107290 · PRAIRIEVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,571 in 86 payments from 20 companies in 2025. Trend: 2023 $1,098 · 2024 $1,525 · 2025 $1,571
Food & beverage: $1,571
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $341 |
| Axsome Therapeutics, Inc. | 5 | $183 |
| GlaxoSmithKline, LLC. | 10 | $170 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $165 |
| Astellas Pharma US Inc | 5 | $88 |
| Lilly USA, LLC | 5 | $85 |
| Abbott Laboratories | 3 | $73 |
| Novo Nordisk Inc | 4 | $65 |
| Antares Pharma, Inc. | 1 | $64 |
| PFIZER INC. | 3 | $60 |
Products named: Auvelity, Kerendia, QULIPTA, TRELEGY ELLIPTA, UBRELVY, VRAYLAR, Veozah, FREESTYLE LIBRE 3.
Industry payments across LA — which companies pay providers there.
